台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    98.8
  • 漲跌
    ▲1.5
  • 漲幅
    +1.54%
  • 成交量
    677
  • 產業
    上櫃 生技醫療類股
  • 309人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
智擎 (4162)籌碼相關-元大-天母 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-天母 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/020.298.6000.0098.800.21,7700.01%
2025/04/010.198.0000.0097.300.11,7730.01%
2025/03/31698.0000.0096.2061,7710.34%
2025/03/281101.504100.50100.50-31,752-0.17%
2025/03/211106.5000.00106.5011,7140.06%
2025/03/060.1111.6800.00111.000.11,6470.00%
2025/02/265115.007116.64115.50-21,553-0.13%
2025/02/2400.001114.50115.00-11,431-0.07%
2025/02/216112.9200.00113.0061,4120.42%
2025/02/1900.001109.50110.00-11,396-0.07%
2025/02/1800.001109.00110.00-11,401-0.07%
2025/02/120.3111.3200.00112.000.31,4080.02%
2025/02/115.1111.031112.00109.004.11,3920.29%
2025/02/101.1118.611.2118.50118.50-0.11,337-0.01%
2025/02/0715.1118.004118.00120.5011.11,3510.82%
2025/02/065.2119.453119.50119.002.21,3290.16%
2025/02/052108.505111.10113.00-31,194-0.25%
2025/01/1600.000.294.5495.10-0.21,386-0.02%
2025/01/0900.000.295.5194.60-0.21,341-0.01%
2025/01/0600.000.3100.22101.50-0.31,259-0.02%
2025/01/0300.00297.7598.30-21,240-0.16%
2024/12/270.392.4000.0092.000.31,2230.02%
2024/12/1600.000.187.1086.30-0.11,216-0.01%
2024/12/1100.000.291.6090.60-0.21,193-0.01%
2024/12/050.195.0000.0094.600.11,1700.01%
2024/11/29297.40197.6097.5011,1360.09%
2024/11/2800.00194.6092.40-11,110-0.09%
2024/11/27195.8000.0094.1011,0950.09%
2024/11/1800.004.199.8196.50-4.11,010-0.40%
2024/11/1500.0013101.2799.90-13989-1.31%
2024/11/141106.507102.36101.50-6971-0.62%
2024/11/1315106.502106.75106.50139461.37%
2024/11/0700.000.1103.00103.50-0.1852-0.01%
2024/11/061105.5000.00102.5018260.12%
2024/11/058106.001108.50106.0077820.89%
2024/11/045101.708.1102.54100.00-3.1758-0.41%
2024/11/013104.175.1107.74105.00-2.1730-0.29%
2024/10/291103.003100.83100.50-2604-0.33%
2024/10/285.5101.051.1103.65102.004.45760.76%
2024/10/25399.80197.5097.4025130.39%
2024/10/240.699.870.299.5098.300.44940.08%
2024/10/1600.000.189.5089.40-0.1476-0.02%
2024/10/1100.00189.1088.30-1502-0.20%
2024/10/08192.1000.0091.1015070.20%
2024/09/2000.002.288.1587.40-2.2644-0.34%
2024/09/09181.9000.0082.0016660.15%
2024/09/0500.000.283.7082.10-0.2689-0.03%
2024/09/0300.00186.6085.70-1713-0.14%
2024/08/21286.5500.0086.6027460.27%
2024/08/201.286.53186.0085.800.27420.03%
2024/08/16184.5000.0084.6017430.13%
2024/08/0900.000.286.1085.40-0.2783-0.03%
2024/07/292.296.35294.6594.500.27360.03%
2024/07/19295.10196.6094.2017080.14%
2024/07/18198.5000.0099.4016760.15%
2024/07/17198.0000.0098.2016580.15%
2024/07/1100.00396.0095.20-3650-0.46%
2024/07/09498.6000.0096.3046680.60%
2024/07/0800.003100.27100.50-3655-0.46%
2024/07/02298.8500.0097.8026230.32%
2024/07/010.5100.5000.00101.000.56100.08%
2024/06/2700.00196.4095.70-1582-0.17%
2024/06/24194.4000.0093.2015890.17%
2024/06/11195.10295.5095.40-1636-0.16%
2024/06/07194.2000.0094.5016440.16%
2024/05/2800.00192.3092.30-1760-0.13%
2024/05/27191.30191.5091.7007760.00%
2024/05/2000.00198.8096.90-1865-0.12%
2024/05/17299.0000.0097.9028720.23%
2024/05/14296.55296.4094.3001,0430.00%
2024/05/0800.00194.1094.00-11,096-0.09%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-2025/03/03
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章
 
 
023小時2